EH&S Specialist I at Gilead Sciences

La Verne, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

AA and 4+ years of relevant experience; OR BA/BS degree and 2+ years of relevant experience; OR MA/MS degree and 0+ years of relevant experience
Preferred: Background in health and safety, chemistry, or environmental science
Preferred: Demonstrated ability to recognize [hazards or issues, as implied]

Responsibilities

Identify, document and reduce potential workplace hazards, including accident investigation, through corrective actions and making recommendations to management
Support the site Sustainability program and plans
Conduct audits, inspections, and training
Provide program specific and general EH&S training, including New Hire Orientation for employees and safety training for contractors
Serve on the after-hours support roster and Emergency Response Team requiring periodic 24 hour on-call availability
Assist with implementing general elements of the La Verne EH&S Program, as defined by local, state and federal agencies
Conduct regular job safety walks and safety audits of workplace
Review and approve, as required, work permits for non-routine high-risk activities
Review site safety plans for construction activities
Act, as needed, as the site EH&S contact for inspections by regulatory agencies
Gather data for the purposes of regulatory reporting and for monitoring, measuring, and communicating environmental performance; prepares report submissions
Maintains records relating to environmental management system initiatives and projects, records of regulatory filings and correspondence
Utilizes established systems and practices to determine and develop approaches to routine problems of moderate complexity, based on analysis of situation or data
Monitors and measures performance in relation to contractual obligations and project deadlines
Monitor incident data in incident reporting platform and follow up on Action item completions
Monitor incident investigation progress and work with item owners to complete in a timely fashion
Assist with chemical inventory monitoring and reporting
Support employee safety off-boarding program

Skills

EH&S Compliance

Hazard Identification

Accident Investigation

Sustainability Programs

Injury Prevention

Risk Reduction

Program Administration

Time Management

Communication

Customer Service

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free